Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Change in Accured Expenses (2016 - 2025)

ENDRA Life Sciences has reported Change in Accured Expenses over the past 6 years, most recently at -$37693.0 for Q4 2021.

  • Quarterly Change in Accured Expenses rose 90.36% to -$37693.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $491104.0 through Dec 2021, up 158.82% year-over-year, with the annual reading at $113287.0 for FY2025, 156.97% up from the prior year.
  • Change in Accured Expenses was -$37693.0 for Q4 2021 at ENDRA Life Sciences, up from -$65736.0 in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $818065.0 in Q2 2021 and troughed at -$390823.0 in Q4 2020.
  • The 5-year median for Change in Accured Expenses is -$51714.5 (2021), against an average of $53546.0.
  • The largest YoY upside for Change in Accured Expenses was 665.83% in 2019 against a maximum downside of 1263.08% in 2019.
  • A 5-year view of Change in Accured Expenses shows it stood at $536173.0 in 2017, then tumbled by 117.49% to -$93756.0 in 2018, then soared by 665.83% to $530503.0 in 2019, then plummeted by 173.67% to -$390823.0 in 2020, then surged by 90.36% to -$37693.0 in 2021.
  • Per Business Quant, the three most recent readings for NDRA's Change in Accured Expenses are -$37693.0 (Q4 2021), -$65736.0 (Q3 2021), and $818065.0 (Q2 2021).